Withania somnifera (L.) Dunal: A potential therapeutic adjuvant in cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of ethnopharmacology"
DOI: 10.1016/j.jep.2020.112759
Abstract: ETHNOPHARMACOLOGICAL RELEVANCE Withania somnifera (L.) Dunal (WS) is one of the most-studied Rasayana botanicals used in Ayurveda practice for its immunomodulatory, anti-aging, adaptogenic, and rejuvenating effects. The botanical is being used for various clinical indications,… read more here.
Keywords: withania somnifera; therapeutic adjuvant; molecular mechanisms; cancer ... See more keywords
The leukotriene receptor antagonist montelukast as a potential therapeutic adjuvant in multiple sclerosis – a review
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2024.1450493
Abstract: Multiple Sclerosis (MS) is a multifactorial autoimmune disease of the central nervous system (CNS). It is characterized by a heightened activation of the immune system with ensuing inflammation, demyelination and neurodegeneration with consequences such as… read more here.
Keywords: multiple sclerosis; therapeutic adjuvant; pathology; leukotriene receptor ... See more keywords